Company / Operating Income
AETHLON MEDICAL INC Operating Income History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$9.3M
FY2024
5-year range
-$12.6M / -$5.9M
FY2020-FY2024
Trend
+26.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2024 after 2 years of decline, reaching -$9M.
Based on SEC 10-K filings.
-$9M in FY2024.
Improved from -$12M to -$9M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income increased 26.1% year-over-year.
- Peak operating income was recorded in FY2015.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$9.3M | +26.1% |
| FY2023 | -$12.6M | -6.2% |
| FY2022 | -$11.9M | -100.7% |
| FY2021 | -$5.9M | +1.2% |
| FY2020 | -$6.0M | +0.0% |
| FY2018 | -$6.0M | -36.8% |
| FY2017 | -$4.4M | +28.1% |
| FY2016 | -$6.1M | -99.6% |
| FY2015 | -$3.1M | +14.5% |
| FY2014 | -$3.6M | -14.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026